Becton Dickinson and Co. (NYSE: BDX) said Friday it bought molecular diagnostic test maker HandyLab Inc. for $275 million, according to Associated Press.
The company first announced the acquisition in October.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
The company has said it would run tests for infections such as MRSA on a diagnostic test platform made by Ann Arbor, Mich.-based HandyLab. The product will be sold as a new version of Becton Dickinson's BD Max system.
Shares of Becton Dickinson rose 24 cents to close at $73.70.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
